INTEGRA LIFESCIENCES HOLDINGS CORP Other Depreciation and Amortization
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Other Depreciation and Amortization of $76.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherDepreciationAndAmortization · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for the quarter ending 2026-06-30 was $38.13M, a 1.18% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for the quarter ending 2026-03-31 was $38.43M, a 3.34% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for the quarter ending 2025-12-31 was $38.43M, a 2.24% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for the quarter ending 2025-09-30 was $38.52M, a 7.12% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for fiscal 2025 was $151.83M, a 7.76% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for fiscal 2024 was $140.89M, a 14.07% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for fiscal 2023 was $123.51M, a 4.41% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP other depreciation and amortization for fiscal 2022 was $118.30M, a 1.28% decline from fiscal 2021.
| Period end | Other Depreciation and Amortization 3 month | Other Depreciation and Amortization 6 month | Other Depreciation and Amortization 9 month | Other Depreciation and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $38.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $76.56M 10-Q · filed 2026-07-29 | $115.00M derived: sum of 3 quarters · filed 2026-07-29 | $153.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $38.43M 10-Q · filed 2026-05-05 | $76.86M derived: sum of 2 quarters · filed 2026-05-05 | $115.38M derived: sum of 3 quarters · filed 2026-05-05 | $153.07M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $38.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $76.95M derived: sum of 2 quarters · filed 2026-02-26 | $114.64M derived: sum of 3 quarters · filed 2026-07-29 | $151.83M 10-K · filed 2026-02-26 |
| 2025-09-30 | $38.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $76.21M derived: sum of 2 quarters · filed 2026-07-29 | $113.40M 10-Q · filed 2025-10-30 | $150.99M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $37.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $74.88M 10-Q · filed 2026-07-29 | $112.47M derived: sum of 3 quarters · filed 2026-07-29 | $148.43M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $37.19M 10-Q · filed 2026-05-05 | $74.78M derived: sum of 2 quarters · filed 2026-05-05 | $110.74M derived: sum of 3 quarters · filed 2026-05-05 | $147.51M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $37.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.55M derived: sum of 2 quarters · filed 2026-02-26 | $110.33M derived: sum of 3 quarters · filed 2026-02-26 | $140.89M 10-K · filed 2026-02-26 |
| 2024-09-30 | $35.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $72.74M derived: sum of 2 quarters · filed 2025-10-30 | $103.30M 10-Q · filed 2025-10-30 | $134.29M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $36.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $67.34M 10-Q · filed 2025-07-31 | $98.33M derived: sum of 3 quarters · filed 2026-02-26 | $128.89M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $30.57M 10-Q · filed 2025-05-05 | $61.55M derived: sum of 2 quarters · filed 2026-02-26 | $92.11M derived: sum of 3 quarters · filed 2026-02-26 | $122.94M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $30.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $61.54M derived: sum of 2 quarters · filed 2026-02-26 | $92.37M derived: sum of 3 quarters · filed 2026-02-26 | $123.51M 10-K · filed 2026-02-26 |
| 2023-09-30 | $30.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $61.38M derived: sum of 2 quarters · filed 2024-11-04 | $92.53M 10-Q · filed 2024-11-04 | $122.02M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $30.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $61.97M 10-Q · filed 2024-07-29 | $91.47M derived: sum of 3 quarters · filed 2025-02-25 | $120.93M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $31.14M 10-Q · filed 2024-05-06 | $60.64M derived: sum of 2 quarters · filed 2025-02-25 | $90.11M derived: sum of 3 quarters · filed 2025-02-25 | $119.72M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $29.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $58.96M derived: sum of 2 quarters · filed 2025-02-25 | $88.58M derived: sum of 3 quarters · filed 2025-02-25 | $118.30M 10-K · filed 2025-02-25 |
| 2022-09-30 | $29.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $59.08M derived: sum of 2 quarters · filed 2023-10-25 | $88.80M 10-Q · filed 2023-10-25 | $119.55M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $29.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $59.34M 10-Q · filed 2023-07-27 | $90.08M derived: sum of 3 quarters · filed 2024-02-28 | $120.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $29.72M 10-Q · filed 2023-04-26 | $60.47M derived: sum of 2 quarters · filed 2024-02-28 | $90.59M derived: sum of 3 quarters · filed 2024-02-28 | $120.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $30.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $60.87M derived: sum of 2 quarters · filed 2024-02-28 | $90.62M derived: sum of 3 quarters · filed 2024-02-28 | $119.84M 10-K · filed 2024-02-28 |
| 2021-09-30 | $30.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $59.88M derived: sum of 2 quarters · filed 2022-10-26 | $89.09M 10-Q · filed 2022-10-26 | $115.27M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $29.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $58.97M 10-Q · filed 2022-07-27 | $85.15M derived: sum of 3 quarters · filed 2023-02-22 | $116.17M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $29.21M 10-Q · filed 2022-04-27 | $55.39M derived: sum of 2 quarters · filed 2023-02-22 | $86.42M derived: sum of 3 quarters · filed 2023-02-22 | $116.09M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $26.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $57.20M derived: sum of 2 quarters · filed 2023-02-22 | $86.88M derived: sum of 3 quarters · filed 2023-02-22 | $116.03M 10-K · filed 2023-02-22 |
| 2020-09-30 | $31.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $60.70M derived: sum of 2 quarters · filed 2021-11-02 | $89.85M 10-Q · filed 2021-11-02 | $117.73M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $29.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $58.83M 10-Q · filed 2021-07-29 | $86.70M derived: sum of 3 quarters · filed 2022-02-24 | |
| 2020-03-31 | $29.15M 10-Q · filed 2021-04-29 | $57.03M derived: sum of 2 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $27.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $109.46M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $81.58M 10-Q · filed 2020-10-29 | |||
| 2018-12-31 | $110.73M 10-K · filed 2021-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |